InvestorsHub Logo
Followers 51
Posts 9097
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Thursday, 09/08/2022 8:52:18 AM

Thursday, September 08, 2022 8:52:18 AM

Post# of 13469
mRNA-4157 Personalized Cancer Vaccine: The Phase 2 trial is fully enrolled and primary data are expected in 4Q 2022.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News